Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #9 Immunic; Phase 2 CALLIPER Data PMS, Possible Phase 3 Path Forward Vidofludimus Calcium, RMS ENSURE Studies Completed 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #9 is a biotech by the name of Immunic (IMUX). The reason why I believe that it is important to go over ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #8 Kura Oncology; Positive Ziftomenib And 7+3 1st-Line AML Data, PDUFA Date November 30th 2025 Ziftomenib Established And ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...